Cosmax Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Cosmax wird ein jährliches Gewinn- und Umsatzwachstum von 26% bzw. 12.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 25.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 24.1% betragen.

Wichtige Informationen

25.7%

Wachstumsrate der Gewinne

25.3%

EPS-Wachstumsrate

Personal Products Gewinnwachstum	13.9%
Wachstumsrate der Einnahmen	12.1%
Zukünftige Eigenkapitalrendite	23.3%
Analystenabdeckung	Good
Zuletzt aktualisiert	25 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

There's Been No Shortage Of Growth Recently For Cosmax's (KRX:192820) Returns On Capital

Sep 13

Cosmax, Inc. (KRX:192820) Stocks Pounded By 32% But Not Lagging Market On Growth Or Pricing

Aug 07

Cosmax, Inc. (KRX:192820) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jul 19

Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?

Jun 18

Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 28% Share Price Surge

May 21

Boasting A 6.1% Return On Equity, Is Cosmax, Inc. (KRX:192820) A Top Quality Stock?

Jan 07

There's A Lot To Like About Cosmax's (KRX:192820) Upcoming ₩900 Dividend

Dec 25

Here's Why Cosmax (KRX:192820) Has A Meaningful Debt Burden

Dec 14

We're Watching These Trends At Cosmax (KRX:192820)

Dec 01

Gewinn- und Umsatzwachstumsprognosen

KOSE:A192820 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (KRW Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	2,668,320	148,633	142,722	206,985	15
12/31/2025	2,412,602	132,827	107,336	176,973	17
12/31/2024	2,134,401	104,265	48,630	138,829	16
6/30/2024	1,973,223	72,862	69,481	196,158	N/A
3/31/2024	1,901,036	69,672	91,250	184,499	N/A
12/31/2023	1,777,494	57,137	140,954	231,021	N/A
9/30/2023	1,741,274	35,147	82,887	160,859	N/A
6/30/2023	1,679,784	31,226	51,988	153,723	N/A
3/31/2023	1,605,534	12,268	41,231	135,594	N/A
12/31/2022	1,600,126	20,848	18,270	102,531	N/A
9/30/2022	1,620,859	53,275	765	72,042	N/A
6/30/2022	1,619,036	53,133	55,589	95,319	N/A
3/31/2022	1,644,377	73,654	49,178	90,445	N/A
12/31/2021	1,591,488	74,436	57,938	100,046	N/A
9/30/2021	1,524,745	49,732	15,703	68,883	N/A
6/30/2021	1,450,488	44,390	45,540	97,307	N/A
3/31/2021	1,399,350	32,640	33,995	93,000	N/A
12/31/2020	1,382,881	21,378	-18,446	41,460	N/A
9/30/2020	1,381,483	40,595	1,225	62,103	N/A
6/30/2020	1,378,240	38,552	-111,927	-1,305	N/A
3/31/2020	1,331,331	27,621	-89,592	17,305	N/A
12/31/2019	1,330,653	31,823	-31,177	74,567	N/A
9/30/2019	1,306,419	28,290	-93,122	5,681	N/A
6/30/2019	1,303,609	29,761	-21,507	30,008	N/A
3/31/2019	1,298,829	32,302	-53,435	-318	N/A
12/31/2018	1,259,717	32,621	-105,967	-54,592	N/A
9/30/2018	1,154,889	28,078	-159,175	-30,777	N/A
6/30/2018	1,048,775	26,092	-164,135	-36,262	N/A
3/31/2018	953,543	24,759	N/A	-16,433	N/A
12/31/2017	883,950	18,855	N/A	-6,617	N/A
9/30/2017	859,621	24,785	N/A	12,527	N/A
6/30/2017	837,213	28,191	N/A	10,850	N/A
3/31/2017	802,622	28,894	N/A	15,353	N/A
12/31/2016	756,964	34,782	N/A	23,469	N/A
9/30/2016	701,781	28,311	N/A	22,797	N/A
6/30/2016	640,402	27,328	N/A	18,506	N/A
3/31/2016	590,437	26,166	N/A	-11,262	N/A
12/31/2015	533,343	21,244	N/A	-6,503	N/A
9/30/2015	565,346	25,940	N/A	-13,870	N/A
6/30/2015	531,873	23,923	N/A	-14,161	N/A
3/31/2015	486,719	21,128	N/A	8,243	N/A
12/31/2014	403,476	19,927	N/A	1,404	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: A192820Das prognostizierte Gewinnwachstum (26.6% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: A192820Die Erträge des Unternehmens (27.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt KR (28.1% pro Jahr).

Hohe Wachstumserträge: A192820Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: A192820Die Einnahmen des Unternehmens (12.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt KR (10.4% pro Jahr).

Hohe Wachstumseinnahmen: A192820Die Einnahmen des Unternehmens (12.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: A192820Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (24.1%)

Cosmax Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target decreased by 8.0% to ₩187,625

Price target increased by 7.6% to ₩213,000

Consensus EPS estimates fall by 11%

Consensus EPS estimates increase by 11%

Price target increased by 11% to ₩132,214

Price target increased by 7.7% to ₩117,571

Recent updates

There's Been No Shortage Of Growth Recently For Cosmax's (KRX:192820) Returns On Capital

Price target decreased by 8.0% to ₩187,625

Cosmax, Inc. (KRX:192820) Stocks Pounded By 32% But Not Lagging Market On Growth Or Pricing

Investor sentiment deteriorates as stock falls 16%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 18%

Cosmax, Inc. (KRX:192820) Shares Could Be 43% Below Their Intrinsic Value Estimate

Price target increased by 7.6% to ₩213,000

Now 24% undervalued

Now 24% undervalued

Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?

Investor sentiment improves as stock rises 17%

Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 28% Share Price Surge

Investor sentiment improves as stock rises 16%

Now 20% overvalued after recent price rise

Now 22% overvalued after recent price rise

We Like These Underlying Return On Capital Trends At Cosmax (KRX:192820)

Statutory Profit Doesn't Reflect How Good Cosmax's (KRX:192820) Earnings Are

Cosmax, Inc.'s (KRX:192820) Share Price Matching Investor Opinion

We Think Cosmax (KRX:192820) Is Taking Some Risk With Its Debt

Consensus EPS estimates fall by 11%

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 11%

Price target increased by 11% to ₩132,214

Price target increased by 7.7% to ₩117,571

Price target increased by 8.2% to ₩108,143

Investor sentiment improves as stock rises 18%

Investor sentiment deteriorates as stock falls 17%

Full year 2022 earnings: EPS misses analyst expectations

Price target increased by 8.0% to ₩94,923

Consensus EPS estimates fall by 11%

Upcoming dividend of ₩550 per share

Price target decreased to ₩75,692

Investor sentiment improved over the past week

Consensus EPS estimates fall by 12%

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Price target decreased to ₩93,357

Price target decreased to ₩97,357

Investor sentiment deteriorated over the past week

Price target decreased to ₩120,267

Investor sentiment deteriorated over the past week

Consensus EPS estimates fall by 37%

Less than half of directors are independent

Price target decreased to ₩147,118

Now 20% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Price target increased to ₩173,150

Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion.

Investor sentiment deteriorated over the past week

Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?

Investors Can Find Comfort In Cosmax's (KRX:192820) Earnings Quality

Will Cosmax (KRX:192820) Multiply In Value Going Forward?

Cosmax, Inc., Annual General Meeting, Mar 26, 2021

What Type Of Shareholders Make Up Cosmax, Inc.'s (KRX:192820) Share Registry?

New 90-day high: ₩113,000

Is It Worth Buying Cosmax, Inc. (KRX:192820) For Its 0.8% Dividend Yield?

Cosmax (KRX:192820) Share Prices Have Dropped 41% In The Last Five Years

Boasting A 6.1% Return On Equity, Is Cosmax, Inc. (KRX:192820) A Top Quality Stock?

There's A Lot To Like About Cosmax's (KRX:192820) Upcoming ₩900 Dividend

Upcoming Dividend of ₩900 Per Share

Here's Why Cosmax (KRX:192820) Has A Meaningful Debt Burden

We're Watching These Trends At Cosmax (KRX:192820)

New 90-day low: ₩99,000

New 90-day high: ₩116,000

New 90-day high - ₩115,000

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie